Stock Quotes & Company News | Reuters.com
Edition:
United States

People: Celgene Corp (CELG.O)

CELG.O on Nasdaq

100.70USD
1 Jul 2016
Change (% chg)

$2.07 (+2.10%)
Prev Close
$98.63
Open
$98.53
Day's High
$101.39
Day's Low
$98.25
Volume
3,407,570
Avg. Vol
4,754,020
52-wk High
$140.72
52-wk Low
$92.98

Barker, Richard 

Dr. Richard W. Barker, D.Phil., OBE., serves as Independent Director of Celgene Corporation since January 20, 2012. He has been member of the Audit Committee of since January 20, 2012. Dr. Barker was formerly Director General of the Association of the British Pharmaceutical Industry (ABPI), a pharmaceutical industry trade association in the United Kingdom, from 2004 to 2011, and served on the Board and Executive Committee of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and as a Council Member of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). Dr. Barker is currently director of the Centre for Accelerating Medical Innovations, a member of the Board of iCO Therapeutics, Inc., a Canadian biotech company, Chairman of Stem Cells for Safer Medicine, a public-private partnership using technology to improve drug safety, Founder and Chairman of the Athenaeum Group, an organization devoted to more effective and efficient pharmaceutical research and development among clinicians, industry leaders and regulators, as well as a senior advisor of Aegate, Ltd., an authentication and traceability service for the pharmaceutical industry.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Hugin

22,472,900

Jacqualyn Fouse

8,073,500

Mark Alles

7,912,170

Peter Kellogg

5,705,640

Thomas Daniel

7,341,980

Scott Smith

4,783,240
As Of  30 Dec 2015